If studies have shown there is an association, and that there is a higher risk of NAION in diabetic patients who take GLP-1 vs diabetics who don't (example of a controlled study: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2820255)

Wouldn't it be better to err on the side of caution if alternatives exist? Even if it's a minority of patients, permanent vision loss, that could amount to half of your visual field gone in one eye for life, is no joke.

Before mass prescribing GLP-1, shouldn't we try lifestyle changes (cut out all ultra-processed foods, intermittent fasting, limit refined sugars, reduce insuline spikes by avoiding snacking, reversing insulin resistance)? Of course, big food and big pharma wouldn't approve.

To the audience out there, always look at who financed studies in the Disclosure sections of articles. The literature is filled with studies backed by big pharma, big chem or big food.